Clinical Trials Directory

Trials / Unknown

UnknownNCT01485718

Effect of Daily Glucomannan in Overweight Patients

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
ProMedica Health System · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Glucomannan is a dietary supplement that has been marketed for weight loss. There is some research that supports this claim but more research is necessary. This is research study is being conducted to determine if the dietary supplement glucomannan is effective for weight loss in adults greater than 18 years of age who are overweight. Participants will be randomized in a 1:1 manner (like the flip of a coin) to receive either glucomannan 575 milligrams, 2 capsules three times daily or placebo, 2 capsules three times daily. The study will last for 12 weeks. At the start of the study participants will be asked questions about current medications and diet/exercise regimen, a weight and height will be obtained, and they will be given a one-month's supply of study supplement. An investigator will call each participant after they have been taking the supplement for 2 weeks to ensure that the participant is tolerating the supplement and answer any questions. Throughout the study, participants will be required to follow-up with investigators in the office every 4 weeks (a total of 3 follow-up appointments). Every 4 weeks, the investigators will weigh participants, count the leftover capsules from the previous month, and ask about any adverse effects you may be experiencing. At the conclusion of the study, a final weight will be compared with the baseline weight to determine if the medication had an effect on weight loss.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGlucomannanParticipants in the glucomannan arm will receive glucomannan 2 capsules 30 minutes before the three largest meals of the day for 12 weeks
DIETARY_SUPPLEMENTPlaceboParticipants in the placebo arm will receive placebo 2 capsules 30 minutes before the three largest meals of the day.

Timeline

Start date
2011-10-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2011-12-05
Last updated
2011-12-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01485718. Inclusion in this directory is not an endorsement.

Effect of Daily Glucomannan in Overweight Patients (NCT01485718) · Clinical Trials Directory